Onesmo Balemba

Dr. Onesmo Balemba

Department of Biological Sciences, University of Idaho, Moscow, ID 83844, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2013 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
CSChloe M. Stenkamp-Strahm
Chloe M. Stenkamp-Strahm
AKAdam J. Kappmeyer
Adam J. Kappmeyer
JSJoe T. Schmalz
Joe T. Schmalz
MGMartin Gericke
Martin Gericke
OBOnesmo Balemba
Onesmo Balemba

1 October 2013 in Autonomic Neuroscience
Verified
Journal Article
Closed access
CSChloe Stenkamp-Strahm
Chloe Stenkamp-Strahm
SPSavannah Patterson
Savannah Patterson
JBJennifer Boren
Jennifer Boren
MGMartin Gericke
Martin Gericke
OBOnesmo Balemba
Onesmo Balemba

4 March 2013 in Animals
Verified
Journal Article
Open access
PDF file
TSTimo Stark
Timo Stark
DMDorah J. Mtui
Dorah J. Mtui
OBOnesmo Balemba
Onesmo Balemba
There is a growing need to find the most appropriate and effective treatment options for a variety of painful syndromes, including conditions affecting the gastrointestinal tract, for treating both veterinary and human patients. The most successful regimen may come through integrated therapies including combining current and novel western drugs with acupuncture and botanical therapies or their derivatives. There is an extensive history and use of plants in African traditional medicine. In this review, we have highlighted botanical remedies used for treatment of pain, diarrheas and inflammation in traditional veterinary and human health care in Africa. These preparations are promising sources of new compounds comprised of flavonoids, bioflavanones, xanthones, terpenoids, sterols and glycosides as well as compound formulas and supplements for future use in multimodal treatment approaches to chronic pain, gastrointestinal disorders and inflammation. The advancement of plant therapies and their derivative compounds will require the identification and validation of compounds having specific anti-nociceptive neuromodulatory and/or anti-inflammatory effects. In particular, there is need for the identification of the presence of compounds that affect purinergic, GABA, glutamate, TRP, opioid and cannabinoid receptors, serotonergic and chloride channel systems through bioactivity-guided, high-throughput screening and biotesting. This will create new frontiers for obtaining novel compounds and herbal supplements to relieve pain and gastrointestinal disorders, and suppress inflammation.

28 February 2015 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
CSChloe M. Stenkamp-Strahm
Chloe M. Stenkamp-Strahm
YNYvonne E. A. Nyavor
Yvonne E. A. Nyavor
AKAdam J. Kappmeyer
Adam J. Kappmeyer
SHSarah Horton
Sarah Horton
MGMartin Gericke
Martin Gericke
OBOnesmo Balemba
Onesmo Balemba

13 March 2020 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
PDF file
YNYvonne Nyavor
Yvonne Nyavor
CBCatherine R. Brands
Catherine R. Brands
GMGeorge May
George May
SKSydney Kuther
Sydney Kuther
JNJessica Nicholson
Jessica Nicholson
OBOnesmo Balemba
Onesmo Balemba
Background: High‐fat diet, microbial alterations and lipopolysaccharide (LPS) are thought to cause enteric diabetic neuropathy and intestinal dysmotility. However, the role of the gut microbiota, lipoteichoic acid (LTA) from Gram‐positive bacteria and short‐chain fatty acids (SCFAs) in the development of diabetic enteric neuropathy and intestinal dysmotility is not well understood. Our aim was to examine the role of the gut microbiota, LTA and SCFAs in the development of diabetic enteric neuropathy and intestinal dysmotility.Methods: We fed germ‐free (GF) and conventionally raised (CR) mice either a high‐fat (HFD) or standard chow diet (SCD) for 8 weeks. We analyzed the microbial community composition in CR mice using 16S rRNA sequencing and damage to myenteric neurons using immunohistochemistry. We also studied the effects of LPS, LTA, and SCFAs on duodenal muscularis externa contractions and myenteric neurons using cultured preparations.Key Results: High‐fat diet ingestion reduced the total number and the number of nitrergic myenteric neurons per ganglion in the duodenum of CR but not in GF‐HFD mice. GF mice had fewer neurons per ganglion compared with CR mice. CR mice fed a HFD had increased abundance of Gram‐positive bacteria. LTA and LPS did not affect the frequency of duodenal muscularis contractions after 24 hours of cultured but reduced the density of nitrergic myenteric neurons and increased oxidative stress and TNFα production in myenteric ganglia. SCFAs did not affect muscularis contractions or injure myenteric neurons.Conclusions & Inferences: Gut microbial alterations induced increase in Gram‐positive bacterial LTA may contribute to enteric neuropathy.

18 February 2019 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
YNYvonne Nyavor
Yvonne Nyavor
RERachel Estill
Rachel Estill
HEHannah Edwards
Hannah Edwards
HOHailey Ogden
Hailey Ogden
KHKaila Heideman
Kaila Heideman
OBOnesmo Balemba
Onesmo Balemba